ARHGAP29 and colorectal carcinoma: ShRNAs targeting ARHGAP29 or MYCT1, as well as LiCl, which promotes GSK3β phosphorylation, were able to abolish TBX21-mediated CRC cell metastasis inhibition in vitro and in vivo.